Please login to the form below

Not currently logged in
Email:
Password:

IVD

This page shows the latest IVD news and features for those working in and with pharma, biotech and healthcare.

NHS could save £7bn with greater diagnostics use

NHS could save £7bn with greater diagnostics use

Report suggests IVD tests could be key to big savings. The NHS could shave up to £7bn off its estimated £22bn deficit by 2023 if it takes advantage of diagnostic tools, ... The report specifically evaluated the savings of three existing IVD tests -

Latest news

  • Industry welcomes European diagnostics regulations Industry welcomes European diagnostics regulations

    scandal. The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) voiced qualified support for the new IVD regulations. ... However, the two trade bodies anticipate the added

  • BioSure UK's home HIV test goes on sale in the UK BioSure UK's home HIV test goes on sale in the UK

    The single use, in vitro diagnostic (IVD) device is said to be 99.7% accurate from three months after suspected exposure to the infection and provides an indication of personal HIV

  • Siemens takes major step into companion diagnostics with pharma tie-ups

    Both partnerships will use Siemens' clinical trial and commercialisation services, as well as its established in vitro diagnostics (IVD) clinical and regulatory capabilities. ... Siemans Healthcare Diagnostics already claims a leadership position in the

  • Slow progress

    a placebo effect, according to Iain Miller, executive director of theranostics at in vitro diagnostics (IVD) company bioMerieux. ... Few IVD products are based above the hundred dollar mark, so when patient populations are in the low thousands, the

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Brexit talks threaten supply of medical technologies Brexit talks threaten supply of medical technologies

    The timing is far from ideal. EU Member States have adopted new In Vitro Diagnostics (IVD) and Medical Devices (MD) Regulations. ... As this is a significant overhaul of the existing EU directives, authorities and companies have five years to adapt to

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    Licence. Diagnostic products IVD. 75. Merck &Co / AstraZeneca. Licence. WEE1 kinase (MK-1775) for ovarian cancer.

  • Pharma deals during September 2013 Pharma deals during September 2013

    Strengthening another of its business units, Roche's diagnostic arm announced a licensing deal with Pacific Bioscience for human in vitro diagnostic (IVD) gene sequencing technology, paying $35m upfront and additional

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics